|1.||Quartaroli, M: 2 articles (11/2001 - 02/2000)|
|2.||Maraia, G: 1 article (11/2001)|
|3.||Fasdelli, N: 1 article (11/2001)|
|4.||Bettelini, L: 1 article (11/2001)|
|5.||Corsi, M: 1 article (11/2001)|
|6.||Bordi, F: 1 article (02/2000)|
|1.||Mononeuropathies (Mononeuritis Multiplex)
02/01/2000 - "In the present study, we examined the effect of an NMDA-glycine site antagonist, GV196771A [E-4, 6-dichloro-3-(2-oxo-1-phenyl-pyrrolidin-3-ylidenemethyl)-1H- indole-2- carboxylic acid sodium salt], on responses to noxious stimuli both in normal rats and during peripheral mononeuropathy induced by chronic constriction injury (CCI) of the sciatic nerve. "
07/01/1999 - "Moreover, GV196771A (1-10 mg/kg p.o.) reversed the hyperalgesia when tested after the establishment of the CCI-induced hyperalgesia. "
11/02/2001 - "GV196771A (0.3-10 mg/kg, p.o.) dose-dependently inhibited established mechanical allodynia when tested 14 or 21 days after nerve ligation. "
07/01/1999 - "In the CCI model GV196771A (3 mg/kg twice a day p.o.), administered before and then for 10 days after nerve ligature, blocked the development of thermal hyperalgesia. "
11/02/2001 - "The effects of the N-methyl-D-aspartate (NMDA) receptor/glycine site antagonist, GV196771A (E-4,6-dichloro-3-(2-oxo-1-phenyl-pyrrolidin-3-ylidenemethyl)-1H-indole-2-carboxylic acid sodium salt), on mechanical allodynia and on tolerance to the antinociceptive effects induced by morphine were evaluated. "
11/02/2001 - "GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice."
|4.||Neuralgia (Stump Neuralgia)
|3.||Glycine (Aminoacetic Acid)
|4.||Glycine Receptors (Glycine Receptor)
|5.||Morphine (MS Contin)